David Perkins
AstraZeneca (Brazil)(BR)Pharmaceutical Product Development (India)(IN)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Oral Health Pathology and Treatment, Synthesis and Biological Evaluation, Spacecraft and Cryogenic Technologies, Rocket and propulsion systems research
Most-Cited Works
- → Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor(2014)591 cited
- → Evidence-Based Clinical Recommendations Regarding Screening for Oral Squamous Cell Carcinomas(2010)345 cited
- → Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase(2007)273 cited
- → Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models(2019)29 cited
- Space Nuclear Thermal Propulsion Test Facilities Subpanel. Final report(1993)
- → One-pot synthesis of bis(amino)-1,2,4-thiadiazoles via direct SNAr(2012)7 cited
- → Synthesis of 3-Substituted 2-Aminopyridines via Displacement of 3-Fluoro-2-nitropyridine(2012)3 cited
- → Comprehensive Synthetic Route Redesign of AZD5991: A High-Complexity Atropisomeric Macrocycle(2025)2 cited
- Space Nuclear Thermal Propulsion Test Facilities Subpanel(1993)